Simon Völkl

5.5k citations

58 papers · 1.0k indexed · 1 hit paper · h-index 23

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
Oncology top 10%
- CAR-T cell therapy research

Papers in

Immunology 38
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 5
- Immune Response and Inflammation 4
Oncology 30
- CAR-T cell therapy research 24
- Cancer Immunotherapy and Biomarkers 4

Co-authors: Andréas Mackensen Dimitrios Mougiakakos Michael Aigner Regina Jitschin Georg Schett Heiko Bruns Fabian Müller Andrej Stoll
Journals: Annals of the Rheumatic Diseases (6 papers)Journal for ImmunoTherapy of Cancer (4 papers)Frontiers in Immunology (3 papers)Scientific Reports (2 papers)Cancers (2 papers)
Partner nations: Germany Switzerland Italy

In The Last Decade

Simon Völkl

56 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells 2025 · 15 citations

Peers

Countries citing papers authored by Simon Völkl

Since Specialization

Citations

This map shows the geographic impact of Simon Völkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Völkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Völkl more than expected).

Fields of papers citing papers by Simon Völkl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Völkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Völkl. The network helps show where Simon Völkl may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Völkl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Völkl Line = papers co-authored together Simon Völkl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality BMC Immunology ·Sarah Lehle, Simon Völkl, Katharina Seitz, Chloë Goossens, Julius Emons, Matthias Ruebner, Sabrina Uhrig, Patrick Ziegler, Anna‐Katharin Theuser, Matthias W. Beckmann, Peter A. Fasching, Hanna Huebner	2025	2
2	Diverging effects of tumor necrosis factor inhibitors and conventional synthetic disease-modifying antirheumatic drugs on immunosenescence and inflammageing in rheumatoid arthritis: a cross-sectional analysis Immunity & Ageing ·Tobias Schwarz, Giovanni Almanzar, Simon Völkl, Martin Feuchtenberger, Johannes Leierer, Christian A. Schmidt, Friederike Deininger, Hans‐Peter Tony, Marc Schmalzing, Martina Prelog	2025	1
3	3D Tumor microenvironment interaction reveals AP‐1 complex regulation and contact‐mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia HemaSphere ·Jana Lindacher, Anne Hartebrodt, Janin Dingfelder, Pascal Lukas, Laeschkir Würthner, Simon Völkl, David B. Blumenthal, Frederik Graw, Kerstin Amann, Manuela Krumbholz, Martina Haibach, Jochen Wilke, Andréas Mackensen, Gloria Lutzny‐Geier	2025	1
4	Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation Transplantation and Cellular Therapy ·Silja Richter, Martin Böttcher, Andrej Stoll, Vanja Zeremski, Simon Völkl, Andréas Mackensen, Arif B. Ekici, Bénédikt Jacobs, Dimitrios Mougiakakos	2024	1
5	TaKeTiNa Music Therapy for Outpatient Treatment of Depression: Study Protocol for a Randomized Clinical Trial Journal of Clinical Medicine ·Ali R. Behzad, Christoph Feldmann-Schulz, Bernd Lenz, Lucy Clarkson, Celine Ludwig, Katharina Luttenberger, Simon Völkl, Johannes Kornhuber, Christiane Mühle, Claudia von Zimmermann	2024	0
6	Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry Molecular Metabolism ·Ariful Haque Abir, Leonie Weckwerth, Artur Wilhelm, Jana Thomas, Clara M. Reichardt, Luis E. Muñoz, Simon Völkl, Uwe Appelt, Markus Mroz, Raluca Niesner, Anja E. Hauser, Rebecca Sophie Fischer, Katharina Pracht, Hans‐Martin Jäck, Georg Schett, Gerhard Krönke, Dirk Mielenz	2024	4
7	Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains Immunobiology ·Hannah Reimann, Carolin Moosmann, Kilian Schober, Vanessa Lang, Johan Verhagen, Julia Zeun, Andréas Mackensen, Anita N. Kremer, Simon Völkl, Michael Aigner	2023	1
8	Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT Blood ·Florian M. Karl, Chunguang Liang, Romy Loschinski, Andrej Stoll, C. Flamann, S. Richter, Christopher Lischer, Simon Völkl, Bénédikt Jacobs, Martin Böttcher, Regina Jitschin, Heiko Bruns, T Fischer, E. Holler, Wolf Rösler, Thomas Dandekar, Andréas Mackensen, Dimitrios Mougiakakos	2023	8
9	OP0141 LONG TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - DATA FROM THE FIRST SEVEN PATIENTS Annals of the Rheumatic Diseases ·J. Taubmann, Fabian Müller, Sebastian Boeltz, Simon Völkl, Michael Aigner, A. Kleyer, I. Minnopoulou, Franco Locatelli, Maria Antonietta D’Agostino, Regina Gary, S. Krestchmann, Soraya Kharboutli, Dimitrios Mougiakakos, Gerhard Krönke, M. Andreas, Georg Schett	2023	11
10	Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy Molecular Therapy — Methods & Clinical Development ·Daniel Núñez, Darshil Patel, J. Volkov, Steven Wong, Zachary Vorndran, Fabian Müller, Michael Aigner, Simon Völkl, Andréas Mackensen, Georg Schett, Samik Basu	2023	28
11	Accumulation of T-cell-suppressive PD-L1^high extracellular vesicles is associated with GvHD and might impact GvL efficacy Journal for ImmunoTherapy of Cancer ·Rebecca Baur, Franziska Karl, Romy Loschinski, Andrej Stoll, Simon Völkl, Andreas Gießl, Cindy Flamann, Heiko Bruns, Ursula Schlötzer‐Schrehardt, Martin Böttcher, Denis M. Schewe, Thomas Fischer, Regina Jitschin, Andréas Mackensen, Dimitrios Mougiakakos	2023	10
12	The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome Scientific Reports ·Silja Richter, Martin Böttcher, Simon Völkl, Andréas Mackensen, Evelyn Ullrich, Bénédikt Jacobs, Dimitrios Mougiakakos	2022	5
13	Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity European Journal of Immunology ·Andreas E. Kremer, (unknown), (unknown), Carsten Willam, Simon Völkl, Johan Verhagen, Susanne Achenbach, Edith D. van der Meijden, Vanessa Lang, Michael Aigner, Clara Maier, Matthias Tenbusch, Klaus Korn, Gloria Lutzny‐Geier, Silvia Spoerl, Richard Strauß, Marcel Vetter, Klaus Überla, Markus F. Neurath, Andréas Mackensen, Mario Schiffer, Holger Hackstein	2021	4
14	CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity Leukemia ·Andrej Stoll, Heiko Bruns, Maximilian Fuchs, Simon Völkl, Falk Nimmerjahn, Meik Kunz, Matthias Peipp, Andréas Mackensen, Dimitrios Mougiakakos	2021	29
15	Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling Cancer Research ·Şehmus Tohumeken, Rebecca Baur, Martin Böttcher, Andrej Stoll, Romy Loschinski, Konstantinos Panagiotidis, Martina Braun, Domenica Saul, Simon Völkl, Andreas S. Baur, Heiko Bruns, Andréas Mackensen, Regina Jitschin, Dimitrios Mougiakakos	2020	49
16	Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA Molecular Cancer Therapeutics ·Carolin Dorothea Strobl, Stefanie Schaffer, Tabea Haug, Simon Völkl, Katrin Peter, Katrin Singer, Martin Böttcher, Dimitrios Mougiakakos, Andréas Mackensen, Michael Aigner	2019	25
17	Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity Frontiers in Immunology ·Tabea Haug, Michael Aigner, Moritz Peuser, Carolin Dorothea Strobl, Kai Hildner, Dimitrios Mougiakakos, Heiko Bruns, Andréas Mackensen, Simon Völkl	2019	30
18	CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells Journal for ImmunoTherapy of Cancer ·Regina Jitschin, Domenica Saul, Martina Braun, Şehmus Tohumeken, Simon Völkl, Roman Kischel, Michael Lutteropp, Cédric Dos Santos, Andréas Mackensen, Dimitrios Mougiakakos	2018	72
19	Bacterial nanocellulose stimulates mesenchymal stem cell expansion and formation of stable collagen-I networks as a novel biomaterial in tissue engineering Scientific Reports ·Martin Vielreicher, Dana Kralisch, Simon Völkl, Fabian Sternal, Andreas Arkudas, Oliver Friedrich	2018	47
20	Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany Cancer Immunology Immunotherapy ·Evelyn Ullrich, Jacobus Bosch, Michael Aigner, Simon Völkl, Diana Dudziak, B. Spriewald, Gerold Schuler, Reinhard Andreesen, Andréas Mackensen	2009	1

About Simon Völkl

Simon Völkl is a scholar working on Immunology, Oncology, Hematology, Biological Psychiatry and Genetics, having authored 58 papers that have together received 1.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (24 papers), Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Immune cells in cancer (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Immunology (461 citations), Oncology (392 citations), Hematology (144 citations), Genetics (110 citations) and Biophysics (39 citations). Simon Völkl has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Andréas Mackensen, Dimitrios Mougiakakos, Michael Aigner, Regina Jitschin, Georg Schett, Heiko Bruns, Fabian Müller, Andrej Stoll, Martin Böttcher and Domenica Saul. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology, Scientific Reports and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact